SCHEMBL322574

SCHEMBL322574

CN(P(c1ccccc1)c1ccccc1)P(c1ccccc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.45
CYP3A4 P08684 1/20 0.45
ESR1 P03372 4/20 0.37
ESR2 Q92731 4/20 0.37
ALDH1A1 P00352 4/20 0.36
TSHR P16473 3/20 0.36
KCNN4 O15554 2/20 0.36
MEN1 O00255 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 1/20 0.33
ALOX12 P18054 1/20 0.33
ACHE P22303 1/20 0.33
HTR2A P28223 1/20 0.33
HRH1 P35367 1/20 0.33
MAPT P10636 1/20 0.33
AOC3 Q16853 1/20 0.33
OPRM1 P35372 1/20 0.33
OPRK1 P41145 1/20 0.33
OPRL1 P41146 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26592463 0.85 TAAR1 (0.45) TDP1CYP3A4ALDH1A1MAPTTAAR1
SCHEMBL1646006 0.82 TDP1 (0.45) TDP1CYP3A4ESR1ESR2ALDH1A1
SCHEMBL16710785 0.81 KDM4E (0.33) TDP1CYP3A4ALDH1A1MEN1KMT2A
SCHEMBL17190347 0.78 TDP1 (0.41) TDP1CYP3A4ESR1ESR2ALDH1A1
SCHEMBL2574194 0.78 MEN1 (0.42) TDP1CYP3A4ESR1ESR2ALDH1A1
SCHEMBL14617914 0.78 CYP3A4 (0.41) TDP1CYP3A4ESR1ESR2ALDH1A1
SCHEMBL16710783 0.76 KDM4E (0.33) TDP1CYP3A4ALDH1A1MEN1KMT2A
SCHEMBL14271678 0.76 TAAR1 (0.39) TDP1CYP3A4ALDH1A1TSHRKMT2A
SCHEMBL28635021 0.75 TDP1 (0.50) TDP1CYP3A4ESR1ESR2ALDH1A1
SCHEMBL29354465 0.74 TDP1 (0.43) TDP1CYP3A4ESR1ESR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260061408-A1 CATALYST COMPOSITION FOR OLEFIN OLIGOMERIZATION INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2026-03-05 US disclosed
CN-119409734-A Bimetallic catalyst coordinated by biphosphine and preparation method and application thereof 中国石油化工股份有限公司 2025-02-11 CN disclosed
CN-118788390-A Cobalt-rhodium bimetallic catalyst coordinated by bidentate phosphorus ligand, and preparation method and application thereof 中国石油化工股份有限公司 2024-10-18 CN disclosed
US-10689310-B2 Method for producing alpha-olefin low polymer MITSUBISHI CHEM CORP (JP) 2020-06-23 US disclosed
US-20180030181-A1 PRODUCTION METHOD OF ALPHA-OLEFIN LOW POLYMER AND PRODUCTION APPARATUS MITSUBISHI CHEM CORP (JP) 2018-02-01 US disclosed
US-20180016205-A1 METHOD FOR PRODUCING ALPHA-OLEFIN LOW POLYMER MITSUBISHI CHEM CORP (JP) 2018-01-18 US disclosed
EP-3214087-A1 LIGAND COMPOUND, CATALYST SYSTEM FOR OLEFIN OLIGOMERIZATION, AND OLEFIN OLIGOMERIZATION METHOD USING SAME LG Chem, Ltd. (KR) 2017-09-06 EP disclosed
US-20170190637-A1 PRODUCTION METHOD AND PRODUCTION APPARATUS OF ALPHA-OLEFIN OLIGOMER MITSUBISHI CHEMICAL CORPORATION (JP) 2017-07-06 US disclosed
EP-2590924-A1 CONVERSION OF ALCOHOLS BP BIOFUELS UK LIMITED (GB) 2013-05-15 EP disclosed
US-20130116481-A1 CONVERSION OF ALCOHOLS BP Biofuels UK Limited (GB) 2013-05-09 US disclosed
WO-2012004572-A1 CONVERSION OF ALCOHOLS BP Biofuels UK Limited (GB) 2012-01-12 WO disclosed
US-7285607-B2 Polymerisation of olefinic compounds SASOL, CHEMICAL INDUSTRIES, LIMITED (ZA) 2007-10-23 US disclosed
US-20060020091-A1 Polymerisation of olefinic compounds SASOL CHEMICAL INDUSTRIES LIMITED (ZA) 2006-01-26 US disclosed
US-5210202-A Chiral phosphorous compounds, a process for their manufacture and their application to the catalysis of enantioselective synthesis reactions SOCIETE CHIMIQUE DES CHARBONNAGES S.A. (FR) 1993-05-11 US disclosed
US-5099077-A Dihydrocarbylphosphioxy substituted groups with amine or phosphinoamines as ligands SOCIETE CHIMIQUE DES CHARBONNAGES S.A. (FR) 1992-03-24 US disclosed
US-4877908-A Chiral phosphorus compounds, a process for their manufacture and their application to the catalysis of enantioselective synthesis reactions NORSOLOR (FR) 1989-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116481-A1 CONVERSION OF ALCOHOLS ADH1C, ADH1A, ADH5 TDP1 3284/4885CYP3A4 864/4885ESR1 1642/4885
US-20260061408-A1 CATALYST COMPOSITION FOR OLEFIN OLIGOMERIZATION CHRND, C5, SCO2 TDP1 445/4885CYP3A4 1662/4885ESR1 546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.